About This Fund
Xiamen Changrong Investment Management is an institutional investor (Conventional VCs) founded in 2007 and headquartered in Xiamen, Fujian, china. Xiamen Changrong Investment Management is a startup VC firm. They make investments in seed-stage, growth-stage and maturity-stage firms. Focused sectors include medical health, TMT industries, education, environmental protection, AI, non-ferrous metals and cultural industries. Portfolio companies include Anji Pharmaceutical, Via Bio, Dogma, etc. Practice areas include Investment Industry. The firm operates as Venture Capital Funds. Key investment sectors include Artificial Intelligence, Healthcare / HealthTech, Biotech / Biopharma, and EdTech. The firm typically invests at the Seed and Growth stage(s). Notable portfolio companies: Anji Pharmaceutical, Via Bio, Dogma.
Investment Focus
Preparing to pitch Xiamen Changrong Investment Management?
CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.
Analyze My Deck →